4.5 Article

Effect of rifampicin on the pharmacokinetics and pharmacodynamics of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in healthy subjects

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Dipeptidyl Peptidase-4 as a New Target of Action for Type 2 Diabetes Mellitus: A Systematic Review

Javaid H. Wani et al.

CARDIOLOGY CLINICS (2008)

Article Pharmacology & Pharmacy

Rifaximin is a gut-specific human pregnane X receptor activator

Xiaochao Ma et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)

Article Pharmacology & Pharmacy

Dual effects of rifampin on the pharmacokinetics of atrasentan

Hao Xiong et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2007)

Article Pharmacology & Pharmacy

Inhibitory and inductive effects of rifampin on the pharmacokinetics of bosentan in healthy subjects

P. L. M. van Giersbergen et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

Article Pharmacology & Pharmacy

Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers

Y. Y. Lau et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)

Article Endocrinology & Metabolism

Dipeptidyl peptidase IV inhibitors: How do they work as new antidiabetic agents?

CHS McIntosh et al.

REGULATORY PEPTIDES (2005)

Review Pharmacology & Pharmacy

Pharmacokinetic interactions with rifampicin - Clinical relevance

M Niemi et al.

CLINICAL PHARMACOKINETICS (2003)

Article Gastroenterology & Hepatology

Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver

SR Vavricka et al.

HEPATOLOGY (2002)